Avalon Pharma Secures $14 Million Credit Renewal with Saudi Investment Bank
Saudi-based Avalon Pharma renews $14 million credit facility with Saudi Investment Bank to support business…
Saudi-based Avalon Pharma renews $14 million credit facility with Saudi Investment Bank to support business…
The controlled release drug delivery market is expected to reach $90 billion by 2030, driven…
Bristol Myers Squibb Company (NYSE:BMY) has been given an average rating of 'Hold' by analysts,…
India's complex drug safety system is plagued by critical gaps, necessitating urgent reforms to ensure…
Bristol Myers Squibb Company (NYSE:BMY) has received an average price target of $56.38 from analysts,…
Jefferies has identified India's next big pharma bet, listing out top CRDMO multibaggers with up…
Panntherapi prepares for Phase IIa clinical trial of PTI5803 in patients with resistant epilepsy, accelerating…
PannTheraPi prepares to conduct its first Phase IIa clinical trial with PTI5803 in patients with…
Anlon Healthcare's IPO has garnered a 50% subscription on the first day, with the retail…
A Fortune 100 firm is investing $14 million in a new Cincinnati facility, creating 140…